Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-01-01 @ 6:51 AM
Study NCT ID:
NCT04579757
Status:
TERMINATED
Last Update Posted:
2025-05-08
First Post:
2020-09-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Sponsor:
Hutchmed
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-02
First Submit QC Date:
None
Study First Post Date:
2020-10-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-04-08
Results First Submit QC Date:
None
Results First Post Date:
2025-05-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-07
Last Update Post Date:
2025-05-08
Last Update Post Date Type:
ACTUAL